The Lancet відкриті
[search 0]
більше

Download the App!

show episodes
 
The Lancet (www.thelancet.com) is a weekly medical journal, renowned for the publication of high-quality peer-reviewed research and reviews from around the world. In the Podcasts our editors discuss journal highlights, including interviews with authors of key articles to provide context and insight to advancements in medicine and health worldwide.
 
The Lancet Voice is a fortnightly podcast from the Lancet family of journals. Lancet editors and their guests unravel the stories behind the best global health, policy and clinical research of the day―and what it means for people around the world. Each episode seeks to inform, challenge, and delight listeners with stories at the crossroads of health, science, policy and current global affairs.
 
The Lancet Gastroenterology & Hepatology is a monthly journal that considers original research, reviews, and personal views in gastroenterology and hepatology from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
 
The Lancet HIV launched in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title delivers a holistic view of the pandemic, publishing original research, comment, and correspondence that unifies clinical, epidemiological, and operational disciplines across a single vision of health for those living with HIV.
 
With a strong clinical focus, The Lancet Child & Adolescent Health will be an independent journal with an international perspective. The monthly journal will present the most influential and innovative practice-changing original research, as well as authoritative reviews and insightful opinion pieces to promote the health of the whole child, from the fetal period through to young adulthood.
 
The Lancet Respiratory Medicine publishes a range of article types in respiratory medicine and critical care. These include Original Research, Reviews, Personal Views, Comments, and News articles. Topics include but are not limited to asthma, COPD, tobacco control, critical care, lung cancer, cystic fibrosis, pneumonia, sarcoidosis, mesothelioma, sleep medicine, and respiratory infections.
 
The Lancet News is a weekly podcast brought to you by The Lancet. Our editors, Tim Dehnel and Dara Mohammadi, report on important, interesting, and sometimes quirky health-related happenings from around the world, while providing a rundown of the latest news from The Lancet, The Lancet Infectious Diseases, The Lancet Neurology, and The Lancet Oncology.
 
The Lancet Psychiatry exists to promote excellence in psychiatric research and practice, and to advocate for the rights of people with mental health problems. Our podcast brings experts together from a wide range of backgrounds to discuss hot topics relevant to mental health in science, society, the law, and the arts. It is vital listening for anyone with an interest in the field.
 
Loading …
show series
 
How does health shape politics? How does politics shape health? Why do some diseases get international attention and funding when others don’t? What role do institutions play? Richard Horton, Eduardo Gomez, and Jeremy Shiffman join Jessamy and Gavin to discuss the talking points from a new Lancet Series on Political Science and Health.…
 
Wilfred Ngwa (Harvard Medical School, Boston, MA, USA; Johns Hopkins University, Baltimore, MD, USA; ICT University, Yaounde, Cameroon), Beatrice Wiafe-Addai (Peace and Love Hospital, Kumasi, Ghana), and David Kerr (University of Oxford, Oxford, UK) discuss the Lancet Oncology Commission on cancer in sub-Saharan Africa.…
 
In 2019 there were 8.6m deaths globally among children and adolescents aged 0-20 years. Almost two decades on from The Lancet’s first ever global health series, on child survival, we've published our new Series, Optimising Child and Adolescent Health and Development. Richard Horton reflects on the progress and setbacks across 20 years of child heal…
 
In 2019 there were 8.6m deaths globally among children and adolescents aged 0-20 years. Almost two decades on from The Lancet’s first ever global health series, on child survival, we've published our new Series, Optimising Child and Adolescent Health and Development. Richard Horton reflects on the progress and setbacks across 20 years of child heal…
 
Georgios Lyratzopoulos (Institute of Epidemiology & Health Care at University College London, London, UK) discusses his population-based study on risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission.The Lancet
 
Imran Ahmed, CEO of the Center For Countering Digital Hate, joins the podcast to discuss the proliferation of misinformation across social media, how medical misinformation has become a profitable industry, why it's been allowed, and what can be done. Read the CCDH's reports, The Disinformation Dozen and Pandemic Profiteers. You can continue the co…
 
Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.The Lancet
 
Prof. Gabriel Leung, Dean of Medicine at the University of Hong Kong, joins Gavin and Jessamy to discuss Hong Kong's recent Omicron wave of COVID-19 and what this variant means for health systems and zero-COVID containment approaches. You can continue the conversation with Jessamy and Gavin on Twitter by following them at @JessamyBagenal and @Gavin…
 
Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection.The Lancet
 
Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology, on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition.The Lancet
 
Lisa Iezzoni (Massachusetts General Hospital, Boston, MA, USA) discusses her Series paper on disabilities and cancer and Jordan Marchak (Children’s Healthcare of Atlanta, Atlanta, GA, USA) discusses her Review on surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors.…
 
Nina Putnis talks to Rashidatu Kamara and Tom Wingfield about their new research on the social and health factors associated with adverse treatment outcomes among people with MDR-TB in Sierra Leone.The Lancet
 
John Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in the April issue of The Lancet Neurology.The Lancet
 
Ibrahim Abubakar, Tolullah Oni, and Obinna Onwujekwe join The Lancet Voice to discuss how Nigeria's history affects the modern-day health system, and the challenges and opportunities for Nigeria in the future. Read the Commission and see infographics and videos: The Lancet Nigeria Commission: investing in health and the future of the nation You can…
 
On this International Women's Day, Lancet editors and the co-chairs of the Women and Cancer Commission discuss the burden of women’s cancer on society and reflect on the questions the Commission is trying to answer.The Lancet
 
Rosie Bradley (Oxford Population Health, University of Oxford, Oxford, UK) discusses her Article on aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression.The Lancet
 
Professor Samuel K. Roberts joins Gavin and Jessamy to discuss racial inequities in the USA and how infectious diseases historically find and exploit the gaps in societies. You can continue the conversation with Jessamy and Gavin on Twitter by following them at @JessamyBagenal and @GavinCleaver. Read our profile: Samuel K Roberts: illuminating hist…
 
Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology.The Lancet
 
What actually is long COVID? How much do we know about what causes it? How many people do we think currently have it? Dr. Claire Steves joins Gavin and Jessamy to talk about the future of long COVID research now that we have a definition for the condition. You can continue the conversation with Jessamy and Gavin on Twitter by following them at @Jes…
 
Swati Patel (University of Colorado Anschutz Medical Center) discusses the epidemiology, clinical features, biology, risk factors, and opportunities for prevention and detection of early-onset colorectal cancers.The Lancet
 
Prof Yi-Long Wu (Guangdong Lung Cancer Institute, Guangzhou, China) and Prof Caicun Zhou (Shanghai Pulmonary Hospital, Shanghai, China) discuss the GEMSTONE 301 and GEMSTONE 302 trials on sugemalimab versus placebo in non-small-cell lung cancer.The Lancet
 
How has our relationship with death changed over the last few decades? What is a "good death"? Dr. Richard Smith, Dr. Libby Sallnow, and Dr. M.R. Rajagopal discuss a new Lancet Commission which looks to address questions about how society treats death and dying. You can continue the conversation with Jessamy and Gavin on Twitter by following them a…
 
Giuseppe Citerio (University of Milano-Bicocca, Milan, Italy) discusses the implications of a study from the CENTER-TBI project of the effect of frailty on 6-month outcome after traumatic brain injury, which is published in the February issue of The Lancet Neurology.The Lancet
 
Prof. Kevin Fenton, Public Health Regional Director for London and advisor to the Mayor of London, joins Gavin and Jessamy to talk about strategies for tackling low vaccination rates, Omicron in London, and living with COVID-19. You can continue the conversation with Jessamy and Gavin on Twitter by following them at @JessamyBagenal and @GavinCleave…
 
Eileen Rubin, author of a paper on advancing precision medicine for acute respiratory distress syndrome discusses her delayed diagnosis and how clinician and researcher goals can differ from those of patients.The Lancet
 
Alberto Costa (Case Western Reserve University, Cleveland, OH, USA) discusses his study on the use of memantine in adolescents and young adults with Down syndrome, which is published in the January issue of The Lancet Neurology.The Lancet
 
Loading …

Короткий довідник

Google login Twitter login Classic login